Cathie Wood's position in Vertex Pharmaceuticals is currently worth $36 Million. That's 0.29% of their equity portfolio (54th largest holding). The first Vertex Pharmaceuticals trade was made in Q3 2020. Since then Cathie Wood bought shares four more times and sold shares on ten occasions. The stake costed the investor $20.5 Million, netting the investor a gain of 76% so far.
Even with the wider market rebound, Cathie Wood hasn’t quite recaptured her initial investment allure. Her flagship fund, the ARK Innovation ETF (NYSEARCA: A...
InvestorPlace, about 1 month agoLove her or loathe her, Cathie Wood’s magnetic pull on the investment world remains undiminished. Wood has uniquely curated portfolios brimming with disrupti...
InvestorPlace, 7 months ago